Table 5.
Drug | Minimum median dose (range) by cohort and/or treatment (g)a |
||||||||
---|---|---|---|---|---|---|---|---|---|
Total population |
With CRRT |
Without CRRT |
|||||||
Obese | Nonobese | P value | Obese | Nonobese | P value | Obese | Nonobese | P valueb | |
MEM | 2 (1–9) | 2 (1–7) | 0.433 | 1 (1–2) | 1 (1–7) | 0.272 | 3 (1–5) | 2 (1–3) | 0.011 |
TZP | 12 (6–76) | 12 (4–76) | 0.422 | 8 (4–76) | 12 (4–16) | 0.921 | 24 (8–40) | 20 (4–76) | 0.674 |
CEF | 4 (2–18) | 10 (2–30) | 0.419 | 2 (2–4) | 6 (2–12) | 0.127 | 12 (2–24) | 12 (2–30) | 0.757 |
CRRT, continuous renal replacement therapy.
Boldface indicates a significant P value.